Interview, Fireside Chat
Deborah DiSanzo: Solving the World’s Health Problems of the Future
- Artificial intelligence is projected to become a major factor in medical imaging and augment physician intelligence to improve job performance and interactions with technology.
- Aggregating patient data pools is expected to lower the cost of care, improve patient outcomes, enable more effective clinical trials, and accelerate the identification of better drug targets.
- Specific AI applications are anticipated to reduce the time to find molecular gene targets to under 12 weeks and allow adverse event coordinators to read and disposition events more accurately than humans.
- Physician burnout is forecasted to continue causing shortages and lengthening wait times, though technology aims to reduce this burden within three years by allowing nurses to focus on patients rather than electronic health records.
- Data aggregation efforts by the Health Transformation Alliance, involving 6 million patients, and the Amazon, J.P. Morgan, and Berkshire Hathaway consortium, involving 1 million patients, are expected to help find paths to lower costs and improve outcomes.
- Millennial demographics are expected to prioritize obtaining the right cure over strict data protection, while the market is predicted to reject data isolation due to the negative impact on everyone.
- Researchers are expected to use aggregated databases to identify the most effective paths for chronic diseases and particular patients, while providers aim to improve radiology reading rooms, assist oncologists, and support primary care physicians.
- Current limitations where 8,000 drug research papers are published daily against a human capacity to read 300 per year highlight the need for AI assistance in processing information.
- Technology implementation at Mayo Clinic has already reduced patient matching to clinical trials from 30 minutes to 8 minutes, with Watson processing every new breast cancer patient last year.
- Cost-saving strategies include focusing on saving lives to drive organizational revenue and addressing the underuse of public place defibrillators, which is expected to see market growth after the first successful in-flight rescue.